10 Dec 2020
Creative Medical Technology Holdings files Patent on Induction of Infectious Tolerance by Ex Vivo Reprogrammed Immune Cells Utilizing ImmCelz® Cellular Immunotherapy
Author: admintech | Filed under: Press ReleasePHOENIX, Dec. 10, 2020 /PRNewswire/ — Creative Medical Technology Holdings trading under the ticker symbol CELZ announced today its patent filing based on data covering utilization of the Company’s ImmCelz® product at generating what is termed in the field of immunology as “infectious…